Nivolumab plus ipilimumab vs. Lenvatinib or sorafebib as first-line treatment for unresectable hepatocellular carcinoma (HCC): 4-year follow-up of CheckMate 9DW | OncLive
Nivolumab plus ipilimumab vs. Lenvatinib or sorafebib as first-line treatment for unresectable hepatocellular carcinoma (HCC): 4-year follow-up of CheckMate 9DW | OncLive
3 months ago
onclive.com
Understanding the Pembrolizumab Treatment Combo in Platinum-Resistant Ovarian Cancers | Oncology Nursing News
Understanding the Pembrolizumab Treatment Combo in Platinum-Resistant Ovarian Cancers | Oncology Nursing News
2 months ago
oncnursingnews.com
Comparing Nivolumab and Pembrolizumab in the Treatment of Lung Cancer | Cancer
Comparing Nivolumab and Pembrolizumab in the Treatment of Lung Cancer | Cancer
Aug 12, 2020
labroots.com
Dr Zhou on Frontline Ivonescimab vs Pembrolizumab in PD-L1 Advanced NSCLC | OncLive
Dr Zhou on Frontline Ivonescimab vs Pembrolizumab in PD-L1 Advanced NSCLC | OncLive
Mar 3, 2025
onclive.com
Dr. Vokes on Selecting Nivolumab or Pembrolizumab for Head and Neck Cancer Treatment | OncLive
Dr. Vokes on Selecting Nivolumab or Pembrolizumab for Head and Neck Cancer Treatment | OncLive
Dec 28, 2016
onclive.com
Pembrolizumab vs. Placebo Paclitaxel ± Bevacizumab for Platinum-Resistant Recurrent Ovarian Cancer: Results From the Phase 3 ENGOT-ov65/KEYNOTE-B96 Study
Pembrolizumab vs. Placebo Paclitaxel ± Bevacizumab for Platinum-Resistant Recurrent Ovarian Cancer: Results From the Phase 3 ENGOT-ov65/KEYNOTE-B96 Study
1 month ago
vumedi.com
First results of nivolumab plus ipilimumab vs nivolumab monotherapy for microsatellite instability high/ mismatch repair-deficient metastatic colorectal cancer from CheckMate 8HW | OncLive
10:33
First results of nivolumab plus ipilimumab vs nivolumab monotherapy for microsatellite instability high/ mismatch repair-deficient metastatic colorectal cancer from CheckMate 8HW | OncLive
Feb 6, 2025
onclive.com
Dr Ashraf on Ivonescimab vs Pembrolizumab as a First-Line Treatment for PD-L1 Advanced NSCLC | OncLive
Oct 14, 2024
onclive.com
12:37
Nivolumab plus Ipilimumab vs Chemotherapy as First-line Treatment for Microsatellite Instability-High/Mismatch Repair Deficient Metastatic Colorectal Cancer: First Results of the CheckMate 8HW Study | OncLive
Jan 31, 2024
onclive.com
9:31
Nivolumab Plus Chemotherapy vs Chemotherapy as First-Line Treatment for Advanced Gastric Cancer/Gastroesophageal Junction Cancer/Esophageal Adenocarcinoma: 4-Year Follow-Up of the CheckMate 649 Study | OncLive
Jan 30, 2024
onclive.com
KEYNOTE-522: Neoadjuvant and Adjuvant Pembrolizumab in TNBC | OncLive
Jun 1, 2022
onclive.com
14:04
EV-302/KEYNOTE-A39: Open-Label, Randomized Phase 3 Study of Enfortumab Vedotin in Combination with Pembrolizumab vs Chemotherapy in Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma | OncLive
Oct 31, 2023
onclive.com
NICE recommends pembrolizumab for 1,600 more people with breast cancer - Cancer Research UK - Cancer News
Nov 14, 2022
cancerresearchuk.org
Dr George on the CheckMate 8Y8 Trial of Nivolumab With/Without Ipilimumab in Untreated RCC | OncLive
Feb 2, 2024
onclive.com
Choosing Between Atezolizumab and Pembrolizumab in Lung Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Jul 2, 2018
targetedonc.com
6:11
Pembrolizumab: Monotherapy Versus Combination Therapy
764 viewsJun 29, 2018
YouTubeOncLive
2:55
How Keytruda Cancer Treatment Works (Update)
84.7K viewsOct 15, 2018
YouTubeLighter Side of Cancer
3:20
How Monoclonal Antibodies Treat Cancer
175K viewsJun 30, 2020
YouTubeNational Cancer Institute
4:00
Cancer Immunotherapy - PD-1 and PD-L1
274.9K viewsAug 5, 2014
YouTubeImmunoOncology
3:12
New Immunotherapy Cancer Treatment Opdivo (nivolumab)
4.4K viewsSep 21, 2017
YouTubeLighter Side of Cancer
4:22
Nivolumab in Non-Small Cell Lung Cancer
7.9K viewsNov 22, 2014
YouTubeOncLive
3:01
Choosing Between Atezolizumab and Pembrolizumab in Lung Cancer
6.7K viewsJul 2, 2018
YouTubeTargeted Oncology
2:05
Pembrolizumab as Second-line Therapy for Advanced Urothelial Carcinoma
11.5K viewsMar 16, 2017
YouTubeNEJM Group
1:39
Pembrolizumab/Lenvatinib Combo Achieves Promising Responses in Anaplastic Thyroid Cancer
1.2K viewsSep 19, 2020
YouTubeTargeted Oncology
1:51
Checkpoint Inhibitors: Taking the Brakes Off the Immune System
147.5K viewsJun 19, 2015
YouTubeCancer Research Institute
2:38
First-Line Carboplatin and Pemetrexed With Pembrolizumab for NSCLC
5K viewsJun 20, 2017
YouTubeTargeted Oncology
1:22
How to pronounce nivolumab
2.8K viewsAug 24, 2021
YouTubeBiomedical Pronunciation Guide
3:22
A PD 1 Inhibitor Fairy Tale
37.2K viewsMar 9, 2017
YouTubebaronerocks
2:44
Pembrolizumab and Chemotherapy in Advanced NSCLC
172 viewsJun 28, 2018
YouTubeOncLive
0:56
Pembrolizumab as adjuvant therapy for TNBC
1.9K viewsSep 16, 2022
YouTubeVJOncology
See more